此页面是自动翻译的，不保证翻译的准确性。请参阅 英文版 对于源文本。

Standard Closure vs. Integrated Mesh-Fascial Closure (IMFC) for Incisional Hernia Repair (IMFC)

2026年10月8日 更新者：Bovino Mattano Facundo、Hospital Zonal General De Agudos Mario V Larrain

Prospective Comparative Evaluation of the Integrated Mesh-Fascial Closure (IMFC) Technique Versus Standard Closure of the Abdominal Wall: A Quasi-Experimental, Non-Randomized Study

This study compares two surgical techniques for closing the abdominal wall in adult patients who have an incisional hernia (a weakness or opening in a previous surgical incision) or who require prophylactic mesh placement during a laparotomy.

In one group, the abdominal wall is closed using the standard technique, in which a polypropylene mesh is fixed independently from the fascial suture. In the other group, Integrated Mesh-Fascial Closure (IMFC) is used, a standardized execution of the technique of mesh incorporation into the fascial closure described by Jamal et al (Hernia, 2013).

The choice of technique is made by the patient after receiving information about both options and providing informed consent. Participants will be followed clinically and with imaging for 18 to 24 months to evaluate the safety, technical feasibility, and reproducibility of the IMFC technique, and to determine the incidence of hernia recurrence in both groups.

研究概览

地位

招聘中

条件

干预/治疗

详细说明

Incisional hernia is one of the most frequent complications of abdominal surgery, with a reported incidence of 10-20% after laparotomy, and recurrence rates after mesh repair reaching 20-30% in long-term follow-up. In conventional techniques, primary fascial closure and mesh fixation are performed as two mechanically independent steps, concentrating tension on the suture line during the acute postoperative period.

The Integrated Mesh-Fascial Closure (IMFC) technique integrates a macroporous polypropylene mesh within a continuous fascial suture line (pattern: mesh → right fascial edge → left fascial edge → mesh), aiming to distribute tensile load simultaneously between the fascia and the prosthesis, potentially reducing the incidence of hernia recurrence compared to standard closure. The principle of incorporating the mesh into the fascial closure was described by Jamal et al in a retrospective series of 72 patients. IMFC standardizes its execution (suture material, 5-mm bites in mesh and fascia, anchoring of the suture line in healthy aponeurosis, and optional minimal peripheral fixation) and evaluates it prospectively against standard closure.

This is a prospective, comparative, quasi-experimental (non-randomized) study conducted at a single center (Hospital Zonal General de Agudos "Dr. Mario V. Larrain," Berisso, Argentina). Eligible patients choose, after informed consent, between standard mesh closure (Group A) or IMFC (Group B). Both groups follow the same clinical and imaging follow-up schedule (days 7, 15, 30; months 2, 6, 12, 18; and a final visit between 18 and 24 months).

The study is designed as an initial, hypothesis-generating comparison of safety, technical feasibility, and reproducibility across surgeons, intended to support a future randomized trial.

研究类型

介入性

注册 (估计的)

60

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

  • 姓名：Emiliano D Gargiulo, MD
  • 电话号码：+54 2215371371

学习地点

  • 阿根廷
    • Buenos Aires
      • Berisso、Buenos Aires、阿根廷、1923
        • 招聘中
        • Hospital Zonal General de Agudos "Dr. Mario V. Larrain
        • 接触：
        • 接触：
          • Emiliano D Gargiulo, MD
          • 电话号码：+54 9 221 5371371

参与标准

研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Adults older than 18 years of age
  • Patients with incisional (ventral) hernia
  • Patients with recurrent incisional hernia
  • Incisional hernias with a diameter greater than 4 cm
  • Patients undergoing laparotomy with an indication for prophylactic mesh placement

Exclusion Criteria:

  • Active surgical site infection
  • Overt abdominal contamination
  • Tissue necrosis or inability to achieve primary fascial closure
  • Non-correctable loss of domain
  • Pregnant women or women of childbearing potential planning pregnancy or not using contraception during the follow-up period
  • Patients belonging to vulnerable populations, in accordance with Law 15.462 and applicable ethical guidelines
  • Active oncologic disease (patients with a cured oncologic history may be included)

学习计划

本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。

研究是如何设计的？

设计细节

  • 主要用途：治疗
  • 分配：非随机化
  • 介入模型：并行分配
  • 屏蔽：单身的

武器和干预

参与者组/臂
干预/治疗
有源比较器：Standard Mesh Closure

Conventional fascial closure using a macroporous polypropylene mesh fixed independently from the closure suture
程序：Standard Fascial Closure with Mesh

Macroporous polypropylene mesh (FILAPROP™/MERIGROW™) plus non-absorbable polypropylene suture, placed using the conventional (independent) technique.
实验性的：Integrated Mesh-Fascial Closure - IMFC

Fascial closure using the Integrated Mesh-Fascial Closure (IMFC) technique: the mesh is incorporated within the trajectory of a single continuous fascial suture (pattern: mesh → right fascial edge → left fascial edge → mesh
程序：Integrated Mesh-Fascial Closure

Same materials integrated into a single continuous suture line using the IMFC technique.

研究衡量的是什么？

主要结果指标

结果测量
措施说明
大体时间
Recurrence rate of incisional hernia
大体时间：18-24 months (final follow-up visit)

Proportion of participants with hernia recurrence, assessed by clinical physical examination and abdominal wall ultrasound, performed in all participants at 6 months and at the final visit (18-24 months). All ultrasound evaluations performed by the same sonographer throughout the study; the sonographer is aware of study participation but blinded to the specific surgical technique (IMFC vs. standard closure) received by each participant.
18-24 months (final follow-up visit)
Rate of Major Intraoperative and Postoperative Complications
大体时间：Throughout study participation (up to 24 months)

Proportion of participants experiencing a serious adverse event (SAE), defined per ICH E6(R3) as death, a life-threatening event, hospitalization or prolongation of hospitalization, persistent or significant disability, or an unplanned surgical reintervention. Postoperative complications additionally graded using the Clavien-Dindo classification system (Grade I-V) to assess severity.
Throughout study participation (up to 24 months)

次要结果测量

结果测量
措施说明
大体时间
Operative time and fascial closure time
大体时间：Intraoperative (during the surgical procedure)

Total operative time (from skin incision to skin closure) and fascial closure time (from start to completion of the mesh-fascial suture line), both measured in minutes and recorded intraoperatively by the surgical team using the operating room clock.
Intraoperative (during the surgical procedure)
Postoperative Pain Assessed by the 0-10 Numeric Pain Rating Scale (NRS-11)
大体时间：Postoperative days 7, 15, and 30

Self-reported postoperative pain intensity measured using the 11-point Numeric Pain Rating Scale (NRS-11), an unabbreviated verbally- or visually-administered numeric scale ranging from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst pain imaginable." Higher scores indicate worse (more severe) pain. Assessed at rest.
Postoperative days 7, 15, and 30
Rate of Early Postoperative Complications (Infection, Seroma, Dehiscence, Hematoma)
大体时间：Up to 30 days postoperative

Proportion of participants with surgical site infection, seroma, wound dehiscence, or hematoma, identified by clinical examination at scheduled postoperative visits (days 7, 15, and 30) and graded according to the Clavien-Dindo classification.
Up to 30 days postoperative
Total Direct Hospital Costs (ARS) Associated with Complications or Reoperations
大体时间：Up to 24 months (exploratory)

Total direct hospital costs, expressed in Argentine pesos (ARS), attributable to management of complications or unplanned reoperations, extracted from institutional administrative and billing records. Exploratory outcome; not powered for formal statistical comparison between groups.
Up to 24 months (exploratory)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

Hospital Zonal General De Agudos Mario V Larrain

调查人员

  • 首席研究员：Facundo B Mattano, MD、Hospital Zonal General de Agudos "Dr. Mario V. Larrain

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年9月28日

初级完成 (估计的)

2030年10月15日

研究完成 (估计的)

2032年10月15日

研究注册日期

首次提交

2026年9月18日

首先提交符合 QC 标准的

2026年9月23日

首次发布 (实际的)

2026年9月25日

研究记录更新

最后更新发布 (实际的)

2026年10月14日

上次提交的符合 QC 标准的更新

2026年10月8日

最后验证

2026年10月1日

更多信息

与本研究相关的术语

关键字

其他相关的 MeSH 术语

其他研究编号

  • IMFC-HL-2026
  • DISPO-2026-226-GDEBA-DIYCTMSAL (其他标识符：Comisión Conjunta de Investigaciones en Salud (CCIS))

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)？

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.

订阅